Transcriptomics

Dataset Information

0

Dual inhibition of Src and MEK decreases the growth of human ovarian cancer cells


ABSTRACT: Treatment of established lines and primary ovarian cancer cultures with Src and MEK inhibitors, saracatinib and selumetinib, respectively, showed target kinase inhibition and synergistic induction of apoptosis and cell cycle arrest in vitro and tumor inhibition in xenografts.

ORGANISM(S): Homo sapiens

PROVIDER: GSE112371 | GEO | 2018/03/28

REPOSITORIES: GEO

Similar Datasets

| PRJNA445838 | ENA
2020-08-24 | GSE147980 | GEO
2012-08-02 | E-GEOD-36622 | biostudies-arrayexpress
2012-08-03 | GSE36622 | GEO
2009-02-21 | E-GEOD-10087 | biostudies-arrayexpress
2009-02-11 | GSE10087 | GEO
2009-02-20 | E-GEOD-10086 | biostudies-arrayexpress
2022-07-04 | GSE165960 | GEO
2017-03-05 | GSE55628 | GEO
2009-02-11 | GSE10086 | GEO